Scripps CME Connection

Non-CME Symposia
Non-CME Symposium Hosted by Epizyme
The First and Only EZH2 Inhibitor Indicated for Patients with Relapsed or Refractory Follicular Lymphoma
Marin Xavier, MD
John Pagel, MD, PhD »
6:45 a.m. - 7:45 a.m.
Non-CME Symposium Hosted by Bristol-Myers Squibb
A Treatment Option for Patients with Myelodysplastic Syndromes
Bart Scott, MD »
11:30 a.m. - 12:30 p.m.
Non-CME Symposium Hosted by Exelixis
A New Combination Treatment for Patients with Advanced Renal Cell Carcinoma
Michael Harrison, MD »
11:30 a.m. - 12:30 p.m.
Please note: all times listed are Pacific Standard Time (PST).
Course Overview
The 2021 Clinical Hematology and Oncology conference is designed for hematologists, oncologists, surgeons, radiation oncologists, internists, and others desiring an update in these specialty areas. The primary objective of this course is to bring together clinicians and leading experts affording them an intimate learning environment in which to discuss new clinical developments and significant advances in diverse areas of hematology and oncology.
Educational Objectives
After attending this live internet activity, participants should be able to:
Target Audience
Non-CME Symposia
Non-CME Symposium Hosted by Epizyme
The First and Only EZH2 Inhibitor Indicated for Patients with Relapsed or Refractory Follicular Lymphoma
Marin Xavier, MD
John Pagel, MD, PhD »
6:45 a.m. - 7:45 a.m.
Non-CME Symposium Hosted by Bristol-Myers Squibb
A Treatment Option for Patients with Myelodysplastic Syndromes
Bart Scott, MD »
11:30 a.m. - 12:30 p.m.
Non-CME Symposium Hosted by Exelixis
A New Combination Treatment for Patients with Advanced Renal Cell Carcinoma
Michael Harrison, MD »
11:30 a.m. - 12:30 p.m.
Please note: all times listed are Pacific Standard Time (PST).